DENTSPLY International Inc. Stock News

U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session. Chico's FAS, Inc. (NYSE: CHS) rose 21.8% to $6.03

Dentsply Sirona Inc (NASDAQ: XRAY) reported Q4 adjusted EPS of $0.46, down from $0.83 a year ago, beating the consensus of $0.32. Sales of $983 million decreased 10.9% Y/Y (organic sales decreased (

DENTSPLY SIRONA's (XRAY) Q4 earnings and revenues decline year over year due to unfavorable foreign currency movement and soft demand across all geographical segments.

Dentsply Sirona posted fourth-quarter adjusted earnings of 46 cents a share, while analysts had penciled in 32 cents a share.

CHARLOTTE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong performance in the Technologies & Equipment business.

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect strong performance in the Technologies & Equipment business.

Expects to Achieve $200 to $225 million in Annual Cost Savings

CHARLOTTE, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and li

It's just a matter of time.

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

DENTSPLY SIRONA's (XRAY) preliminary results meet market expectation. While certain product categories are driving growth, macro headwinds continue to hurt the top line.

DENTSPLY SIRONA's (XRAY) preliminary results meet market expectation. While certain product categories are driving growth, macro headwinds continue to hurt the top line.

On Wednesday, Dentsply Sirona Inc (NASDAQ: XRAY) announced interim FY22 sales above the high end of the company's prior outlook range of $3.85 billion to $3.88 billion.  FY22 adjusted EPS is expec